| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.32 | 0.03 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.03 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.099 | 0.04 |